HTRS2025.O8C.4 Efficacy and Safety of Giroctocogene Fitelparvovec in Adults With Moderately Severe to Severe Hemophilia A: Results From the Phase 3 AFFINE Gene Therapy Trial

Authors
Category Primary study
ConferenceResearch and Practice in Thrombosis and Haemostasis
Year 2025
This article has no abstract
Epistemonikos ID: 0045da7c4f1657932bb026a7afbb8167324a8138
First added on: Jan 10, 2026